Androgen receptor antagonists: a patent review (2008 – 2011)

ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment

(2012) N. J. Clegg et al.   CANCER RESEARCH

The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy

(2011) Suzanne E. Wardell et al.   BIOCHEMICAL PHARMACOLOGY

Androgen Receptor Rediscovered: The New Biology and Targeting the Androgen Receptor Therapeutically

(2011) Charles J. Ryan et al.   JOURNAL OF CLINICAL ONCOLOGY

Recent developments in antiandrogens and selective androgen receptor modulators

(2011) Bernard Haendler et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Tissue- and cell-specific functions of the androgen receptor revealed through conditional knockout models in mice

(2011) Karel De Gendt et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

(2011) Mark O. Goodarzi et al.   Nature Reviews Endocrinology

Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer

(2011) Martin Ligr et al.   PLoS One

Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases

(2011) Xiaotun Zhang et al.   PLoS One

Androgens and epithelial ovarian cancer: What's the connection?

(2010) Beth Y. Karlan et al.   CANCER BIOLOGY & THERAPY

Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor

(2010) Raymond J. Andersen et al.   CANCER CELL

Combined androgen blockade for prostate cancer: Review of efficacy, safety and cost-effectiveness

(2010) Hideyuki Akaza   CANCER SCIENCE

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

(2010) Howard I Scher et al.   LANCET

Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

(2010) P. A. Watson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Androgen Action in Prostate Cancer

(2010) Sujit Basu et al.   Hormones & Cancer

Alternative Inhibition of Androgen Receptor Signaling: Peptidomimetic Pyrimidines As Direct Androgen Receptor/Coactivator Disruptors

(2009) Jillian R. Gunther et al.   ACS Chemical Biology

A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth

(2009) Z. Guo et al.   CANCER RESEARCH

Do Animal Models of Polycystic Ovary Syndrome Help to Understand Its Pathogenesis and Management? Yes, but Their Limitations Should be Recognized

(2009) Stephen Franks   ENDOCRINOLOGY

Molecular cell biology of androgen receptor signalling

(2009) Nigel C. Bennett et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Cyclic Pyrrole−Imidazole Polyamides Targeted to the Androgen Response Element

(2009) David M. Chenoweth et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Minireview: Not Picking Pockets: Nuclear Receptor Alternate-Site Modulators (NRAMs)

(2009) Terry W. Moore et al.   MOLECULAR ENDOCRINOLOGY

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

(2009) Wennuan Liu et al.   NATURE MEDICINE

Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

(2009) C. Tran et al.   SCIENCE

Evaluation of the rodent Hershberger bioassay on intact juvenile males—Testing of coded chemicals and supplementary biochemical investigations

(2009) A. Freyberger et al.   TOXICOLOGY

Systemic therapy after first-line docetaxel in metastatic castration-resistant prostate cancer

(2009) Emma K Beardsley et al.   Current Opinion in Supportive and Palliative Care

Membrane androgen receptor activation in prostate and breast tumor cells: Molecular signaling and clinical impact

(2008) Natalia Papadopoulou et al.   IUBMB LIFE

Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT

(2008) Stephen Chia et al.   JOURNAL OF CLINICAL ONCOLOGY

Androgen receptor functions in male and female physiology

(2008) Takahiro Matsumoto et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY